Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Maia Biotechnology

Clinical trials sponsored by Maia Biotechnology, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug combo aims to revive immune response in lung cancer Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New drug combo aims to revive immune response in lung cancer

Disease control Recruiting now

This phase 3 trial tests whether a new drug called THIO, given before the immunotherapy cemiplimab, can help people with advanced non-small cell lung cancer who have already tried two prior treatments. About 300 participants will be randomly assigned to receive either the THIO-ce…

Phase 3 • Sponsor: Maia Biotechnology • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC